Decisions regarding the type of therapy and where it is provided should balance the potential for patient benefit and the risk of cross-infection of others.

Providers need to be alert to appropriate infection prevention and control procedures for aerosol-generating procedures (described in the ED Design Layout section).
Patient presentations may vary from mild to critical illness, we recommend  the National COVID-19 Clinical Evidence taskforce flowcharts that provide a ready and  accessible guide to management. [Link]
Treatment is based on the following principles.

  • Respiratory support to maintain adequate oxygenation.
  • Specific agents including antiviral drugs and and therapies directed against the inflammatory response.
  • Supportive care including identification and management of complications

  • Assess severity and potential for deterioration
  • Oxygen supplementation and respiratory support
  • Use of high-flow nasal oxygen (HFNO) and Non-Invasive Ventilation (NIV)
  • Management of ventilation for adults
  • Specific therapeutics
  • Supportive care
  • Other considerations
  • References
  • Section disclaimer
  • Resources